LAPTM4B and gastric cancer: Kaplan-Meier survival curves showed there was a tendency of shorter overall survival (OS) in GC patients with LAPTM4B-35 positive expression compared to the negative ones (P = 0.064, log-rank = 3.425) (Fig 3A).